Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai, 200032, China.
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Int J Clin Oncol. 2020 Jan;25(1):100-109. doi: 10.1007/s10147-019-01538-3. Epub 2019 Sep 17.
Survival for patients with colorectal cancer (CRC) has improved over the past decades. However, it is unclear whether older patients have benefited to the same extent as younger patients.
The Surveillance, Epidemiology, and End Results (SEER) 9 registries database was queried for CRC patients from 1975 to 2009. We presented yearly data for survival with overlying loess-smoothing lines across all age groups. Another cohort was created using the SEER 18 registries database for patients diagnosed with CRC from 1973 to 2014. Yearly data for surgery-performed rate, stage proportion, and multivariate hazard ratio were performed with overlying smoothing lines across all age groups.
In the analysis SEER 9, 5-year cause-specific survival (CSS) of patients aged ≤ 54, 55-64, and 65-74 years showed robust increase since 1975; however, the survival of patients aged 75-84 years remained low despite modest improvement, and patients aged 85 or older even showed no survival gains since 1990. In the analysis of SEER 18, there has been a steady increase in the survival of patients aged ≤ 54, 55-64, 65-74, and 75-84 years as time period advanced; however, of CRC patients aged ≥ 85 years, the survival curves of period 1990-1999 and 2000-2012 could not be distinguished from each other presented with negligibly a small gap from the curve of 1980-1989.
The strong interaction between age and year of diagnosis implies that older patients have benefited less over time than younger patients, especially for patients aged ≥ 85 years.
在过去几十年中,结直肠癌(CRC)患者的生存率有所提高。然而,尚不清楚老年患者是否像年轻患者一样从中受益。
从 1975 年至 2009 年,对 Surveillance,Epidemiology,and End Results(SEER)9 登记数据库中的 CRC 患者进行了查询。我们呈现了所有年龄段的生存率逐年数据,并在上面叠加了 loess 平滑线。使用 SEER 18 登记数据库创建了另一个队列,其中包含 1973 年至 2014 年诊断为 CRC 的患者。对所有年龄段的手术实施率、分期比例和多变量风险比进行了逐年数据分析,并在上面叠加了平滑线。
在 SEER 9 的分析中,≤54 岁、55-64 岁和 65-74 岁的患者的 5 年特异性生存率(CSS)自 1975 年以来显著增加;然而,75-84 岁患者的生存率仍然较低,尽管有所改善,而 85 岁或以上的患者自 1990 年以来甚至没有生存获益。在 SEER 18 的分析中,随着时间的推移,≤54 岁、55-64 岁、65-74 岁和 75-84 岁的患者的生存率稳步提高;然而,对于≥85 岁的 CRC 患者,1990-1999 年和 2000-2012 年期间的生存曲线彼此无法区分,与 1980-1989 年的曲线之间几乎没有差距。
年龄与诊断年份之间的强烈相互作用表明,老年患者的受益时间不如年轻患者长,尤其是对于≥85 岁的患者。